Paligent Inc, formerly named Paligent, merged with Heaven's Door Corp (NASDAQ:HDC) in 2000, and was subsequently acquired by International Fight League, Inc. in a reverse merger transaction in Novemeber of 2006. The company previously discovered and developed drugs for the prevention and treatment of disease and transplant rejection and infectious diseases with a focus on AIDS and cancer